Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$36.08 - $54.3 $8.36 Million - $12.6 Million
231,697 Added 264.52%
319,287 $12 Million
Q4 2023

Jan 24, 2024

SELL
$34.32 - $57.55 $2.74 Million - $4.6 Million
-79,904 Reduced 47.71%
87,590 $4.9 Million
Q3 2023

Oct 26, 2023

BUY
$40.86 - $62.98 $623,360 - $960,822
15,256 Added 10.02%
167,494 $6.91 Million
Q2 2023

Aug 10, 2023

SELL
$50.96 - $58.72 $8.65 Million - $9.97 Million
-169,839 Reduced 52.73%
152,238 $8.5 Million
Q1 2023

May 04, 2023

BUY
$35.33 - $55.79 $150,682 - $237,944
4,265 Added 1.34%
322,077 $18 Million
Q4 2022

Feb 09, 2023

BUY
$24.4 - $41.3 $7.75 Million - $13.1 Million
317,812 New
317,812 $11.6 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.55B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.